NEOGENOMICS Regulatory Monday, October 5, 2026 0.00 Neutral

Bylaws amended to allow arbitrary director changes

NeoGenomics amended its bylaws to allow electing up to 11 directors and altering their number by one per year, contingent on shareholder approval.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed